Laurus Labs Ltd | Pharma multibagger momentum stock
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs)
Financial: excellent
Market Cap = 23,185 Cr. ROCE = 22.2 % ROE = 20.4 %
Debt to equity = 0.45 Promoter holding = 27.2 % Piotroski score = 5.00
Quick ratio = 0.64 Current ratio = 1.31 Profit Var 3Yrs = 41.6 %
Sales growth 3Years = 27.3 % Return on assets = 11.2 %
in sector rotation now its pharma time to move up.
big player heavily buying in pharma sector.
this stock is big one momentum stock. since long consolidation RSI up move in momentum zone.
we have to ready for participate and grab the opportunity . moreover financially also stable pharma company.
Note: I am not SEBI registered financial Adviser. I solely present my views on chart .I do not charge any kind of service. This is not buy sell recommendation.
If you like my ideas than like boost and follow me for more ideas.
Thanks and comment freely
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs)
Financial: excellent
Market Cap = 23,185 Cr. ROCE = 22.2 % ROE = 20.4 %
Debt to equity = 0.45 Promoter holding = 27.2 % Piotroski score = 5.00
Quick ratio = 0.64 Current ratio = 1.31 Profit Var 3Yrs = 41.6 %
Sales growth 3Years = 27.3 % Return on assets = 11.2 %
in sector rotation now its pharma time to move up.
big player heavily buying in pharma sector.
this stock is big one momentum stock. since long consolidation RSI up move in momentum zone.
we have to ready for participate and grab the opportunity . moreover financially also stable pharma company.
Note: I am not SEBI registered financial Adviser. I solely present my views on chart .I do not charge any kind of service. This is not buy sell recommendation.
If you like my ideas than like boost and follow me for more ideas.
Thanks and comment freely
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.